PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP InhibitionYasir H. Ibrahim, José Baselga, Patricia Cozar et al.|Cancer Discovery|2012Cited by 622